BioSamples – The Block Between Bench and Bedside
A 2018 survey conducted by the UK agency Medicines Discovery Catapult found that 80% of SMEs (small to medium sized biotechs) found accessing biosamples from…
A 2018 survey conducted by the UK agency Medicines Discovery Catapult found that 80% of SMEs (small to medium sized biotechs) found accessing biosamples from…
The development of no less than five separate, highly effective vaccines against COVID-19 in less than a year is nothing short of miraculous. As the…
In June of this year, the Pacific Northwest battled unprecedented “heat domes,” which climate scientists agree would not have occurred in the absence of man-made…
Today, we can enjoy innovations that were once considered science fiction, thanks to Data Science. Machine Learning (ML) and Artificial Intelligence (AI) have revolutionized the…
uMotif and Xperiome, a global healthtech company specialising in rare disease are to collaborate through a partnership that will bring value to both life science…
As the life sciences industry continues to embrace virtual interactions over the long term, digital is becoming more than just a way for field reps…
The journey of a biospecimen used for medical research begins with the donor and ends in a research laboratory. What happens between those two points…
Top-level management from pharma companies and IT leaders from the manufacturing and packaging sector get together at Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2021) on…
The events of 2020 changed how the life sciences industry works – possibly forever. Prior to the emergence of COVID-19, some Contract Research Organisations (CROs)…
The pressures on overstretched NHS resources are well documented and well understood. With increasing focus on better integrated and connected care in the community, especially…